Women's Health10 min read·Published September 17, 2026

Treatment for PCOS and Infertility: What Helps, What to Ask, and Where Weight Care Fits

PCOS can make ovulation less predictable, but many people with PCOS can become pregnant with the right evaluation and care plan.

Treatment for PCOS and Infertility: What Helps, What to Ask, and Where Weight Care Fits

PCOS is a common, treatable cause of infertility because it can disrupt ovulation. Treatment usually starts with confirming the diagnosis, checking metabolic health, and matching care to pregnancy goals. For anovulatory infertility, ovulation-induction medicines such as letrozole are commonly used; weight and insulin-resistance care may also help selected patients 1.

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

What does PCOS have to do with infertility?

PCOS-related infertility often comes down to ovulation. If an egg is not released regularly, it is harder to time intercourse or insemination, and there are fewer chances to conceive over 12 months of trying 1.

How irregular ovulation can make conception harder

Polycystic ovary syndrome, or PCOS, is a hormone and metabolic condition linked with irregular periods, higher androgen levels, and sometimes polycystic-appearing ovaries on ultrasound 1, 10. Anovulation means ovulation does not happen; oligo-ovulation means it happens less often than expected 1.

This does not mean pregnancy is impossible. It means the path often starts with confirming whether ovulation is happening and then choosing care that fits the person’s goals, age, metabolic health, and partner factors 1.

Why PCOS can also affect miscarriage risk and pregnancy monitoring

PCOS can overlap with insulin resistance, obesity, prediabetes, type 2 diabetes, high blood pressure, and sleep apnea symptoms, all of which can matter before and during pregnancy 1, 10. Because of that, clinicians often check metabolic health before conception and monitor pregnancy more closely when risk factors are present 10.

Why many people with PCOS can still become pregnant

Many people with PCOS can become pregnant, especially when care is matched to the reason conception has been difficult 1. If irregular ovulation is the main issue, ovulation-induction treatment may be enough; if there are tubal, uterine, sperm, or age-related factors, a fertility specialist may recommend a different path 1.

How is PCOS usually confirmed before fertility treatment?

PCOS is usually confirmed by looking at cycle pattern, androgen symptoms or labs, and ovarian appearance on ultrasound. Clinicians also rule out other causes of irregular periods before starting fertility treatment 10.

Cycle history, androgen symptoms, labs, and ultrasound

The Rotterdam criteria are commonly used in adults: PCOS may be diagnosed when 2 of 3 features are present after other causes are excluded: irregular ovulation, clinical or lab evidence of hyperandrogenism, and polycystic ovarian morphology on ultrasound 10. Hyperandrogenism can show up as acne, excess facial or body hair, or elevated androgen labs 10.

Other causes of irregular periods that clinicians may rule out

Before fertility treatment, clinicians may check for thyroid disease, high prolactin, pregnancy, primary ovarian insufficiency, adrenal conditions, medication effects, and other causes of irregular bleeding 10. This matters because the right treatment changes when the cause is not PCOS 10.

Partner testing and semen analysis

Even when PCOS is present, infertility evaluation often includes partner testing, including semen analysis when sperm is part of the pregnancy plan 1. Treating only ovulation can miss male-factor infertility, tubal disease, or uterine factors 1.

When to ask for referral to an OB-GYN or reproductive endocrinologist

A referral is reasonable if periods are very irregular, pregnancy has not happened after an appropriate trying interval, age makes timing important, there has been repeated pregnancy loss, or there are known sperm, tubal, uterine, or endocrine concerns 1, 10.

PCOS infertility treatment is not one treatment. The main options include lifestyle and metabolic care, letrozole, clomiphene citrate, metformin, gonadotropins, assisted reproductive technology such as IVF, and less commonly surgery 1, 2.

Lifestyle and weight-management care when clinically appropriate

Lifestyle intervention has been studied in women with PCOS for metabolic health, including insulin resistance and cardiometabolic risk markers 3. For people with overweight, obesity, prediabetes, or type 2 diabetes risk, weight-management care may be part of the plan, but it is supportive care rather than an ovulation-induction treatment 1, 3.

Letrozole for ovulation induction

Letrozole is an aromatase inhibitor used for ovulation induction in anovulatory PCOS, and contemporary evidence summaries often favor it over clomiphene for first-line treatment when pregnancy is the goal 1, 2. This PCOS ovulation-induction use is not letrozole’s FDA-labeled indication. Side effects can include hot flashes, headache, fatigue, and dizziness, and fertility treatment with letrozole should be clinician-guided because monitoring and pregnancy timing matter 1.

Clomiphene citrate

Clomiphene citrate is another ovulation-induction medicine used in PCOS-related infertility 1. It may be discussed when letrozole is not a fit, but it can cause hot flashes, mood symptoms, visual symptoms, ovarian cysts, and a higher chance of multiple pregnancy than natural conception, so clinician monitoring is important 1.

Metformin and insulin-resistance care

Metformin is used for insulin resistance and metabolic care in PCOS and has also been studied in reproductive outcomes 1, 4. It is not the only fertility treatment for every patient; common side effects include nausea, diarrhea, and abdominal discomfort, and clinicians consider kidney function and other safety factors before use 1, 4.

Myo-inositol has also been studied in PCOS, including a randomized trial comparing myo-inositol plus metformin with metformin alone 4. This is supplement-related research, not a Chia offering, and people trying to conceive should review supplements with a clinician because quality, interactions, and pregnancy timing can matter 4, 9.

Gonadotropins and monitored cycles

Gonadotropins are injectable fertility hormones used in monitored cycles when simpler ovulation-induction options are not appropriate or have not worked 1. They require closer ultrasound and lab monitoring because risks include ovarian hyperstimulation and multiple pregnancy 1.

IVF or other assisted reproductive technology

In vitro fertilization, or IVF, and other assisted reproductive technology may be considered when ovulation induction is not enough, when other infertility factors are present, or when timing is a major concern 1. IVF can help bypass some barriers, but it is more intensive, more expensive, and still carries risks such as ovarian hyperstimulation and multiple pregnancy depending on the protocol 1.

Laparoscopic ovarian drilling: why it is less commonly first choice

Laparoscopic ovarian drilling is a surgical option that has been studied for ovulation in PCOS, but it is less commonly a first choice because non-surgical treatments are available and surgery carries risks such as bleeding, infection, adhesions, and ovarian tissue damage 1, 2.

3-min quiz

Considering weight care as part of a PCOS plan?

Chia does not provide fertility procedures or ovulation-induction medicines. For eligible adults, we offer clinician-reviewed weight-management care with semaglutide injection or tirzepatide tablets or injection when clinically appropriate. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.

How do diet, exercise, and sleep fit into PCOS fertility care?

Lifestyle care can support metabolic health in PCOS, especially when insulin resistance, prediabetes, type 2 diabetes risk, overweight, or obesity are present. It should not be framed as a stand-alone fertility cure, and it should not delay fertility evaluation when timing matters 1, 3.

What a PCOS-supportive eating pattern usually emphasizes

A PCOS-supportive eating pattern usually emphasizes enough protein, high-fiber carbohydrates, unsaturated fats, and fewer highly processed foods, with attention to blood sugar and sustainability 3, 10. For more detail on food patterns, see our guide to a PCOS diet for weight loss.

Why sustainable weight change may matter more than a specific diet label

For patients whose clinician recommends weight loss, the plan that can be followed safely over time is usually more useful than a strict label like low-carb, keto, or low-fat 3. In a randomized lifestyle-intervention study in women with PCOS, researchers measured metabolic health during structured lifestyle care, supporting the role of lifestyle as part of metabolic management 3.

Physical activity and insulin resistance

Physical activity can improve insulin sensitivity and cardiometabolic health in many people, including those with PCOS-related metabolic risk 3, 10. A clinician can help tailor activity if there is pelvic pain, joint pain, sleep apnea symptoms, diabetes, or high blood pressure 10.

Sleep, stress, and fertility evaluation

Sleep habits are relevant in infertility populations, and one study examined sleep patterns among women with infertility 5. Sleep changes alone should not be presented as a treatment for PCOS infertility, but poor sleep, snoring, daytime sleepiness, or suspected sleep apnea should be discussed with a clinician 5, 10.

What should you do first if you have PCOS and want to get pregnant?

Trying to conceive with PCOS usually starts with a careful preconception visit, not a single supplement or app. The goal is to confirm ovulation patterns, review medicines, and check health risks before pregnancy 1, 10.

  • Track bleeding and cycle length, but do not rely on an app alone to prove ovulation; irregular cycles can make app predictions less accurate 1.
  • Review all medicines and supplements before conception, including acne medicines, hormone medicines, metabolic medicines, and over-the-counter products 10.
  • Ask about A1C, fasting glucose or other diabetes screening, lipids, blood pressure, thyroid testing, prolactin, and other labs your clinician thinks fit your history 10.
  • Discuss prenatal vitamins, folic acid, vaccination status, and pregnancy safety with a clinician before trying to conceive 10.
  • Seek care promptly for very heavy bleeding, severe pelvic pain, fainting, a positive pregnancy test with pain or bleeding, or bleeding after long gaps without periods 10.

Where can Chia fit into PCOS care if weight is part of the plan?

Chia can fit only in the weight-management part of PCOS care for eligible adults, not the fertility-procedure or ovulation-induction part. We do not offer PCOS diagnosis as a standalone service, letrozole, clomiphene, metformin, gonadotropins, IVF, or fertility monitoring.

For eligible adults, Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection. Semaglutide is a GLP-1 receptor agonist; Wegovy, Ozempic, and Rybelsus are brand names that contain semaglutide in FDA-approved products, while compounded semaglutide is prepared by a licensed 503A pharmacy when prescribed 11. Tirzepatide is a dual GIP/GLP-1 receptor agonist; Zepbound and Mounjaro are brand names that contain tirzepatide in FDA-approved products, while compounded tirzepatide is prepared by a licensed 503A pharmacy when prescribed 12.

GLP-1 and GIP/GLP-1 weight-loss medicines are not fertility drugs. In FDA labeling, semaglutide products used for chronic weight management include pregnancy-related warnings and advise stopping before a planned pregnancy because of the long washout period; tirzepatide labeling also includes pregnancy warnings and notes that it can reduce exposure to oral contraceptives during initiation and dose escalation 11, 12.

Chia optionForms listed in Chia catalogCurrent starting priceWhere it may fitImportant limits
SemaglutideInjection; microdosing plans available when clinically appropriatePlans currently start at $249/moWeight-management care for eligible adults after licensed-provider reviewNot a fertility drug; pregnancy planning and contraception discussion are important
TirzepatideTablets or injection; microdosing plans available when clinically appropriateTablets currently start at $249/mo; injection currently starts at $299/moWeight-management care for eligible adults after licensed-provider reviewNot a fertility drug; discuss pregnancy timing, contraception, side effects, and contraindications

Chia’s process is 100% online: you complete a short health questionnaire, then a licensed US provider reviews it and prescribes only where clinically appropriate. If prescribed, medication is compounded in the US by a state-licensed 503A compounding pharmacy and shipped to your door; dosing is provider-guided and adjusted over time through the patient portal.

Side effects of GLP-1 and GIP/GLP-1 medicines can include nausea, vomiting, diarrhea, constipation, abdominal pain, and appetite changes; labeling also includes warnings about conditions such as pancreatitis, gallbladder disease, kidney injury from dehydration, and certain thyroid tumor risks 11, 12. If pregnancy is possible, treatment timing should be planned with a clinician before starting 11, 12.

If you want a broader overview of medication choices, our guides to PCOS medicine for weight loss, prescriptions for weight loss, and Zepbound for weight loss explain how weight-management medicines differ.

How do PCOS infertility treatments compare?

Treatment choice depends on the main goal: pregnancy now, cycle regulation, androgen symptom control, metabolic health, or weight management. Fertility treatments and metabolic treatments can overlap in care, but they are not the same thing 1, 10.

OptionMain goalWho may discuss itEvidence strengthMonitoring needsKey limitations
Lifestyle and weight-management careMetabolic health; may support fertility care in selected patientsPeople with PCOS plus insulin resistance, overweight, obesity, prediabetes, or cardiometabolic riskSupported for metabolic health in PCOS studiesWeight, blood pressure, labs, symptomsNot an ovulation-induction treatment by itself
LetrozoleOvulation inductionPeople with anovulatory PCOS trying to conceiveOften favored as first-line in evidence summariesCycle tracking; sometimes ultrasound or labsSide effects and pregnancy timing require clinician guidance
Clomiphene citrateOvulation inductionPeople who are not using letrozole or need another approachLongstanding fertility optionCycle tracking; sometimes ultrasound or labsCan raise multiple-pregnancy risk and cause visual or mood symptoms
MetforminInsulin-resistance and metabolic care; sometimes reproductive supportPeople with insulin resistance, prediabetes risk, or selected fertility plansStudied in PCOS, but not enough as the only fertility plan for everyoneGlucose markers, kidney function, side effectsGI side effects are common; role depends on the patient
GonadotropinsStronger ovulation stimulationPeople needing monitored fertility cycles after other options or in selected casesEstablished fertility treatmentClose ultrasound and lab monitoringHigher risk of ovarian hyperstimulation and multiple pregnancy
IVF or assisted reproductive technologyFertilization and embryo transfer outside the bodyPeople with additional infertility factors, failed simpler treatment, or time-sensitive careEstablished fertility treatmentSpecialist monitoring, procedures, labsMore intensive and costly; not needed for every person with PCOS
GLP-1 or GIP/GLP-1 weight-management medicineWeight and metabolic careEligible adults when pregnancy is not current and timing is plannedActive ingredients have FDA-approved products for weight or diabetes indications; compounded outcomes are not FDA-evaluatedSide effects, contraindications, pregnancy planningNot a fertility drug and should not be used as an ovulation-induction plan

Questions to ask before starting any medication include: What problem are we treating? How will we know if it is working? What monitoring is needed? What side effects should I watch for? What should I do if I get a positive pregnancy test? These questions are especially important when a treatment affects ovulation, metabolism, or pregnancy timing 1, 10.

Supplements and newer pathways are being studied, but early or narrow research should not be turned into a promise. Myo-inositol, resveratrol, and neurokinin 3 receptor antagonist research are examples where the details of the trial matter 4, 6, 7, 9.

A randomized trial studied resveratrol in women with PCOS undergoing assisted reproduction and measured mitochondrial and reproductive outcomes 6. That does not make resveratrol a proven infertility treatment for every person with PCOS, and it is not a Chia offering.

Fezolinetant, a neurokinin 3 receptor antagonist, has been studied in a randomized controlled trial for PCOS-related hormone outcomes 7. It should not be framed as a standard fertility treatment for PCOS infertility based on that trial alone 7.

Myo-inositol has been studied in PCOS, including pregnancy-related research in a randomized clinical trial 9. People who are trying to conceive should treat supplements like active health decisions and review them with an OB-GYN, reproductive endocrinologist, or primary clinician 9, 10.

What symptoms or situations should prompt medical care sooner?

Get medical care sooner if bleeding, pain, pregnancy timing, or health risks make waiting unsafe. PCOS is common, but severe symptoms or higher-risk fertility situations deserve prompt care 10.

  • No periods for several months, very heavy bleeding, bleeding with dizziness, or bleeding after a long gap without periods 10.
  • Severe pelvic pain, one-sided pain, fever, fainting, or pain with a positive pregnancy test 10.
  • Known diabetes, high blood pressure, kidney disease, or symptoms of sleep apnea, such as loud snoring and daytime sleepiness 10.
  • Age-related fertility timing concerns, especially when delaying evaluation could reduce treatment options 1.
  • Repeated pregnancy loss, known tubal disease, uterine concerns, or known male-factor infertility 1.

3-min quiz

Start with a clinician-reviewed plan

If weight is part of your PCOS care plan and pregnancy is not current, Chia can review eligibility for compounded semaglutide injection or compounded tirzepatide tablets or injection. We do not provide fertility procedures or ovulation-induction medicines. A licensed US provider reviews your health history and prescribes only when clinically appropriate; compounded medications are not FDA-approved.

FAQ

References

  1. 1.Costello MF, Misso ML, Balen A, et al. Infertility management in women with polycystic ovary syndrome. Human Reproduction Update. 2019.
  2. 2.Ghasemi Tehrani H, et al. The effects of first-line pharmacological treatments for reproductive outcomes in polycystic ovary syndrome: a systematic review and network meta-analysis. Reproductive Biology and Endocrinology. 2023.
  3. 3.Dietz de Loos A, Jiskoot G, Beerthuizen A, et al. Metabolic health during a randomized controlled lifestyle intervention in women with PCOS. European Journal of Endocrinology. 2021.
  4. 4.Nazirudeen R, Sridhar S, Priyanka R, et al. A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome. Clinical Endocrinology. 2023.
  5. 5.Eisenberg E, Legro RS, Diamond MP, et al. Sleep Habits of Women With Infertility. The Journal of Clinical Endocrinology and Metabolism. 2021.
  6. 6.Ardehjani NA, Agha-Hosseini M, Nashtaei MS, et al. Resveratrol ameliorates mitochondrial biogenesis and reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproduction: a randomized, triple-blind, placebo-controlled clinical trial. Journal of Ovarian Research. 2024.
  7. 7.Fraser GL, Obermayer-Pietsch B, Laven J, et al. Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism. 2021.
  8. 8.National Library of Medicine. Polycystic Ovary Syndrome (PCOS) and Infertility, clinical trial record NCT00883766. ClinicalTrials.gov. 2026.
  9. 9.van der Wel AWT, Frank CMC, Bout-Rebel R, et al. Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial. JAMA. 2025.
  10. 10.Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility. 2023.
  11. 11.U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2024.
  12. 12.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. 2025.

About this article

Chia Health Editorial TeamEvidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides